A patient with bilateral pheochromocytoma as part of a Von Hippel-Lindau (VHL) syndrome type 2C

World Journal of Surgical Oncology

Volumn 5, Issue , 2007, Pages

  Schreinemakers, Jennifer M J ^a   Zonnenberg, Bernard A ^a   Höppener, Jo W M ^a   Hes, Frederik J ^b   Rinkes, Inne H M ^a   Lips, Cornelis J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOXAZOSIN; GLYCINE; HYDROCORTISONE; METOPROLOL; MINERALOCORTICOID; NIFEDIPINE; PRASTERONE; SERINE;

ADRENALECTOMY; ADULT; ARTICLE; CASE REPORT; CHROMOSOME 3P; CLINICAL FEATURE; ECHOGRAPHY; EXON; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; HUMAN; INTRAUTERINE GROWTH RETARDATION; LAPAROSCOPIC SURGERY; MATERNAL HYPERTENSION; MISSENSE MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; PREECLAMPSIA; TUMOR VOLUME; VON HIPPEL LINDAU DISEASE; ADRENAL TUMOR; CESAREAN SECTION; FOLLOW UP; GENETICS; METHODOLOGY; MUTATION; NEWBORN; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURITY; PRENATAL DIAGNOSIS; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; SMALL FOR DATE INFANT; TREATMENT OUTCOME;

ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADULT; CESAREAN SECTION; FEMALE; FOLLOW-UP STUDIES; GERM-LINE MUTATION; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, SMALL FOR GESTATIONAL AGE; MAGNETIC RESONANCE IMAGING; MUTATION, MISSENSE; PHEOCHROMOCYTOMA; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; RISK ASSESSMENT; TREATMENT OUTCOME; VON HIPPEL-LINDAU DISEASE;

EID: 37749054602     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-5-112     Document Type: Article

References (27)

1. Amar L Bertherat J Baudin E Ajzenberg C Bressac-de Paillerets B Chabre O Chamontin B Delemer B Giraud S Murat A Niccoli-Sire P Richard S Rohmer V Sadoul JL Strompf L Schlumberger M Bertagna X Plouin PF Jeunemaitre X Gimenez-Roqueplo AP Genetic testing in pheochromocytoma or functional paraganglioma J Clin Oncol 2005, 23:8812-8818 10.1200/JCO.2005.03.1484 16314641
2. Bravo EL Tagle R Pheochromocytoma: State-of-the-art and future prospects Endocr Rev 2003, 24:539-553 10.1210/er.2002-0013 12920154
3. Dahia PL Evolving concepts in pheochromocytoma and paraganglioma Curr Opin Oncol 2006, 18:1-8 10.1097/01.cco.0000198017.45982.06 16357557
4. Kebebew E Duh QY Benign and malignant pheochromocytoma: Diagnosis, treatment, and follow-Up Surg Oncol Clin N Am 1998, 7:765-789 9735133
5. Neumann HP Bausch B McWhinney SR Bender BU Gimm O Franke G Schipper J Klisch J Altehoefer C Zerres K Januszewicz A Eng C Smith WM Munk R Manz T Glaesker S Apel TW Treier M Reineke M Walz MK Hoang-Vu C Brauckhoff M Klein-Franke A Klose P Schmidt H Maier-Woelfle M Peczkowska M Szmigielski C Eng C Germ-line mutations in nonsyndromic pheochromocytoma N Engl J Med 2002, 346:1459-1466 10.1056/NEJMoa020152 12000816
6. Stolle C Glenn G Zbar B Humphrey JS Choyke P Walther M Pack S Hurley K Andrey C Klausner R Linehan WM Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene Hum Mutat 1998, 12:417-423 10.1002/ (SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K 9829911
7. van Heerden JA Roland CF Carney JA Sheps SG Grant CS Long-term evaluation following resection of apparently benign pheochromocytoma(s)/ paraganglioma(s) World J Surg 1990, 14:325-329 10.1007/BF01658516 1973322
8. Whalen RK Althausen AF Daniels GH Extra-adrenal pheochromocytoma J Urol 1992, 147:1-10 1729490
9. Opocher G Conton P Schiavi F Macino B Mantero F Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1 Fam Cancer 2005, 4:13-16 10.1007/s10689-004-6128-y 15883705
10. Hes FJ Hoppener JW Lips CJ Clinical review 155: Pheochromocytoma in Von Hippel-Lindau disease J Clin Endocrinol Metab 2003, 88:969-974 10.1210/ jc.2002-021466 12629069
11. Maher ER Kaelin WG Jr. von Hippel-Lindau disease Medicine (Baltimore) 1997, 76:381-391 10.1097/00005792-199711000-00001 9413424
12. Proye CA Vix M Jansson S Tisell LE Dralle H Hiller W "The" pheochromocytoma: A benign, intra-adrenal, hypertensive, sporadic unilateral tumor. Does it exist? World J Surg 1994, 18:467-472 10.1007/ BF00353738 7725730
13. Hoffman MA Ohh M Yang H Klco JM Ivan M Kaelin WG Jr. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF Hum Mol Genet 2001, 10:1019-1027 10.1093/hmg/10.10.1019 11331612
14. Friedrich CA Genotype-phenotype correlation in von Hippel-Lindau syndrome Hum Mol Genet 2001, 10:763-767 10.1093/hmg/10.7.763 11257110
15. Kim WY Kaelin WG Role of VHL gene mutation in human cancer J Clin Oncol 2004, 22:4991-5004 10.1200/JCO.2004.05.061 15611513
16. MELMON KL ROSEN SW LINDAU'S DISEASE. REVIEW OF THE LITERATURE AND STUDY OF A LARGE KINDRED Am J Med 1964, 36:595-617 10.1016/ 0002-9343(64)90107-X 14142412
17. Los M Jansen GH Kaelin WG Lips CJ Blijham GH Voest EE Expression pattern of the von Hippel-Lindau protein in human tissues Lab Invest 1996, 75:231-238 8765323
18. Richards FM Schofield PN Fleming S Maher ER Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis Hum Mol Genet 1996, 5:639-644 10.1093/hmg/5.5.639 8733131
19. Stebbins CE Kaelin WG Jr. Pavletich NP Structure of the VHL-ElonginC-ElonginB complex: Implications for VHL tumor suppressor function Science 1999, 284:455-461 10.1126/science.284.5413.455 10205047
20. Mitch WE Goldberg AL Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway N Engl J Med 1996, 335:1897-1905 10.1056/ NEJM199612193352507 8948566
21. Kaelin WG Jr. Molecular basis of the VHL hereditary cancer syndrome Nat Rev Cancer 2002, 2:673-682 10.1038/nrc885 12209156
22. van der HE de Krijger RR Dinjens WN Weeks LE Bonjer HJ Bruining HA Lamberts SW Koper JW Germline mutations in the vhl gene in patients presenting with phaeochromocytomas Int J Cancer 1998, 77:337-340 10.1002/ (SICI)1097-0215(19980729)77:3<337::AID-IJC5>3.0.CO;2-P 9663592
23. Zbar B Kishida T Chen F Schmidt L Maher ER Richards FM Crossey PA Webster AR Affara NA Ferguson-Smith MA Brauch H Glavac D Neumann HP Tisherman S Mulvihill JJ Gross DJ Shuin T Whaley J Seizinger B Kley N Olschwang S Boisson C Richard S Lips CH Lerman M. Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan Hum Mutat 1996, 8:348-357 10.1002/ (SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3 8956040
24. Beroud C Joly D Gallou C Staroz F Orfanelli MT Junien C Software and database for the analysis of mutations in the VHL gene Nucleic Acids Res 1998, 26:256-258 147207 9399847 10.1093/nar/26.1.256
25. Gnarra JR Tory K Weng Y Schmidt L Wei MH Li H Latif F Liu S Chen F Duh FM. Mutations of the VHL tumour suppressor gene in renal carcinoma Nat Genet 1994, 7:85-90 10.1038/ng0594-85 7915601
26. Hes FJ van der Luijt RB [Von Hippel-Lindau disease: Protocols for diagnosis and periodical clinical monitoring. National Von Hippel-Lindau Disease Working Group] Ned Tijdschr Geneeskd 2000, 144:505-509 10735135
27. Hes FJ van der Luijt RB Lips CJ Clinical management of Von Hippel-Lindau (VHL) disease Neth J Med 2001, 59:225-234 10.1016/S0300-2977(01)00165-6 11705642